Teratoma: Clinical Trials

12 trials for Teratoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 terminated. 12 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Completed 10, Terminated 2
Phase 23Completed 2, Terminated 1

Follow Teratoma: new trials by email Literature Review of Teratoma trials Research Report on Teratoma

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
carboplatin, dasatinib, etoposide phosphate - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1 / Phase 2TerminatedCity of Hope Medical Center72008-09-102026-11-04
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin
filgrastim, carboplatin, ifosfamide - Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor
Phase 1 / Phase 2CompletedMemorial Sloan Kettering Cancer Center262006-08-012016-05-18
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
carboplatin, talabostat mesylate, temozolomide - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1CompletedNational Institutes of Health Clinical Center (CC)262005-12-012012-03-15
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
ipilimumab, therapeutic allogeneic lymphocytes - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Phase 1CompletedNational Cancer Institute (NCI)212003-04-012013-03-27
ABT-751 in Treating Young Patients With Refractory Solid Tumors
ABT-751 - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1CompletedNational Institutes of Health Clinical Center (CC)902002-03-012012-03-15
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy
ixabepilone - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1CompletedNational Institutes of Health Clinical Center (CC)302001-11-012012-03-15
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
beclomethasone dipropionate - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center2000-07-012010-04-02
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
O6-benzylguanine, temozolomide - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1CompletedNational Cancer Institute (NCI)2000-06-012015-04-29
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
doxorubicin HCl liposome - Childhood Soft Tissue Sarcoma, Childhood Liver Cancer
Phase 1CompletedNational Cancer Institute (NCI)1999-07-012024-03-04
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
amifostine trihydrate, busulfan, filgrastim - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1TerminatedMasonic Cancer Center, University of Minnesota131998-11-012017-11-29
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
recombinant interleukin-12 - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 1CompletedIndiana University1997-10-012014-09-10
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
filgrastim, carboplatin, cyclophosphamide - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins211997-05-312020-02-17

Narrower conditions

Testicular Neoplasms (12)  ·  Neuroblastoma (11)  ·  Ovarian Neoplasms (10)  ·  Central Nervous System Neoplasms (9)  ·  Wilms Tumor (9)  ·  Astrocytoma (8)  ·  Kidney Neoplasms (8)  ·  Medulloblastoma (8)  ·  Ovarian Germ Cell Cancer (8)  ·  Choroid Plexus Neoplasms (7)  ·  Familial ependymoma (7)  ·  Liver Neoplasms (7)  ·  Neuroectodermal Tumors, Primitive, Peripheral (7)  ·  Oligodendroglioma (7)

Broader conditions

Endocrine System Diseases (12)  ·  Female Urogenital Diseases (12)  ·  Female Urogenital Diseases and Pregnancy Complications (12)  ·  Genital Diseases (12)  ·  Genital Diseases, Male (12)  ·  Genital Neoplasms, Male (12)  ·  Gonadal Disorders (12)  ·  Male Urogenital Diseases (12)  ·  Neoplasms by Histologic Type (12)  ·  Neoplasms by Site (12)  ·  Neoplasms, Germ Cell and Embryonal (12)  ·  Testicular Diseases (12)  ·  Urogenital Diseases (12)  ·  Urogenital Neoplasms (12)  ·  Adnexal Diseases (11)

Interventions

Carboplatin (4)  ·  Filgrastim (3)  ·  Peripheral Blood Stem Cell Transplantation (3)  ·  Ifosfamide (2)  ·  Temozolomide (2)  ·  ABT751 (1)  ·  Amifostine (1)  ·  Beclomethasone (1)  ·  Blotting, Western (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  CTLA-4 Antigen (1)  ·  Cyclophosphamide (1)  ·  Dasatinib (1)  ·  Etoposide (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  National Institutes of Health Clinical Center (CC) (3)  ·  City of Hope Medical Center (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Indiana University (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Countries

United States (12)

Top investigators

Elizabeth Fox, MD (2)  ·  AeRang Kim, MD (1)  ·  Allen R. Chen, MD, PhD, MHS (1)  ·  Darren Feldman, MD (1)  ·  David Hockenbery, MD (1)  ·  Elizabeth Lowe (1)  ·  Ewa Carrier (1)  ·  Holly Meany, MD (1)  ·  John P. Perentesis, MD (1)  ·  Judith K. Sato, MD (1)  ·  Katherine Warren, MD (1)  ·  Michael J. Robertson, MD (1)

Results publications

PMID 16234526, PMID 16914576, PMID 18281544, PMID 18974373, PMID 19075272, PMID 19430790, PMID 20044751, PMID 20460632, PMID 9849694

NIH funding

P30CA033572 (1), R01CA093891 (1)